Efficacy and safety of ICS/LABA/LAMA FDCs in COPD: a network meta-analysis
P. Rogliani (Roma (RM), Italy), M. Cazzola (Roma (RM), Italy), S. Verri (Roma (RM), Italy), F. Camardelli (Roma (RM), Italy), L. Calzetta (Parma, Italy), L. Calzetta (Roma (RM), Italy)
Source: International Congress 2022 – COPD clinical studies and exacerbations
Session: COPD clinical studies and exacerbations
Session type: Thematic Poster
Number: 3616
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Rogliani (Roma (RM), Italy), M. Cazzola (Roma (RM), Italy), S. Verri (Roma (RM), Italy), F. Camardelli (Roma (RM), Italy), L. Calzetta (Parma, Italy), L. Calzetta (Roma (RM), Italy). Efficacy and safety of ICS/LABA/LAMA FDCs in COPD: a network meta-analysis. 3616
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|